145 related articles for article (PubMed ID: 26111740)
1. Referral of Ovarian Cancer Patients for Genetic Counselling by Oncologists: Need for Improvement.
Ricci MT; Sciallero S; Mammoliti S; Gismondi V; Franiuk M; Bruzzi P; Varesco L
Public Health Genomics; 2015; 18(4):225-32. PubMed ID: 26111740
[TBL] [Abstract][Full Text] [Related]
2. Referral patterns for genetic counselling of women diagnosed with tubo-ovarian or peritoneal high-grade serous carcinoma (HGSC) within the Auckland Gynaecological Oncology Centre.
Burling MJ; Gamet K; Eva L; Tan AL
Aust N Z J Obstet Gynaecol; 2019 Jun; 59(3):444-449. PubMed ID: 30883681
[TBL] [Abstract][Full Text] [Related]
3. Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
Kentwell M; Dow E; Antill Y; Wrede CD; McNally O; Higgs E; Hamilton A; Ananda S; Lindeman GJ; Scott CL
Gynecol Oncol; 2017 Apr; 145(1):130-136. PubMed ID: 28162234
[TBL] [Abstract][Full Text] [Related]
4. Streamlining genetic testing for women with ovarian cancer in a Northern California health care system.
Powell CB; Laurent C; Ciaravino G; Garcia C; Han L; Hoodfar E; Karlea A; Kobelka C; Lee J; Littell RD; Roh J; Vay A; Kushi LH
Gynecol Oncol; 2020 Oct; 159(1):221-228. PubMed ID: 32778409
[TBL] [Abstract][Full Text] [Related]
5. The integration of BRCA testing into oncology clinics.
Percival N; George A; Gyertson J; Hamill M; Fernandes A; Davies E; Rahman N; Banerjee S
Br J Nurs; 2016 Jun; 25(12):690-4. PubMed ID: 27345073
[TBL] [Abstract][Full Text] [Related]
6. Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing.
Cohen PA; Nichols CB; Schofield L; Van Der Werf S; Pachter N
Int J Gynecol Cancer; 2016 Jun; 26(5):892-7. PubMed ID: 27051053
[TBL] [Abstract][Full Text] [Related]
7. Oncologist-led
Yoon SY; Wong SW; Lim J; Ahmad S; Mariapun S; Padmanabhan H; Hassan NT; Lau SY; Ch'ng GS; Haniffa M; Ong WP; Rethanavelu K; Moey LH; Keng WT; Omar J; Mohd Abas MN; Yong CM; Ramasamy V; Md Noor MR; Aliyas I; Lim MCK; Suberamaniam A; Mat Adenan NA; Ahmad ZA; Ho GF; Abdul Malik R; Subramaniam S; Khoo BP; Raja A; Chin YS; Sim WW; Teh BH; Kho SK; Ong ESE; Voon PJ; Ismail G; Lee CL; Abdullah BZ; Loo KS; Lim CS; Lee SJ; Lim KJL; Shafiee MN; Ismail F; Latiff ZA; Ismail MP; Mohamed Jamli MF; Kumarasamy S; Leong KW; Low J; Md Yusof M; Ahmad Mustafa AM; Mat Ali NH; Makanjang M; Tayib S; Cheah N; Lim BK; Fong CK; Foo YC; Mellor Abdullah M; Tan TS; Chow DSY; Ho KF; Raman R; Radzi A; Deniel A; Teoh DCY; Ang SF; Joseph JK; Ng PHO; Tho LM; Ahmad AR; Muin I; Bleiker E; George A; Thong MK; Woo YL; Teo SH
J Med Genet; 2022 Mar; 59(3):220-229. PubMed ID: 33526602
[TBL] [Abstract][Full Text] [Related]
8. Patterns of referral and uptake of BReast CAncer (BRCA) gene testing of eligible women with ovarian cancer in New Zealand.
Fraser K; Tan AL; Innes C; Stephens R; Tristram A; Petrich S; Lintott C; Sykes PH; Gamet K; Christian A; Simcock B
N Z Med J; 2019 Feb; 132(1490):26-35. PubMed ID: 30789886
[TBL] [Abstract][Full Text] [Related]
9. Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
Powell CB; Littell R; Hoodfar E; Sinclair F; Pressman A
Int J Gynecol Cancer; 2013 Mar; 23(3):431-6. PubMed ID: 23354368
[TBL] [Abstract][Full Text] [Related]
10. Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.
Uyar D; Neary J; Monroe A; Nugent M; Simpson P; Geurts JL
Gynecol Oncol; 2018 Jun; 149(3):565-569. PubMed ID: 29653687
[TBL] [Abstract][Full Text] [Related]
11. Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.
Hoskins PJ; Gotlieb WH
CA Cancer J Clin; 2017 Nov; 67(6):493-506. PubMed ID: 28881380
[TBL] [Abstract][Full Text] [Related]
12. Changing patterns of referrals and outcomes of genetic participation in gynaecological-oncology multidisciplinary care.
Pokharel HP; Hacker NF; Andrews L
Aust N Z J Obstet Gynaecol; 2016 Dec; 56(6):633-638. PubMed ID: 27530527
[TBL] [Abstract][Full Text] [Related]
13. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
[TBL] [Abstract][Full Text] [Related]
14. Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
Lheureux S; Karakasis K; Harter P; Scott C; Bacon M; Bryce J; Le Fur N; Pujade-Lauraine E; Oza AM
Gynecol Oncol; 2016 Jan; 140(1):90-4. PubMed ID: 26475959
[TBL] [Abstract][Full Text] [Related]
15. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
Nippert I; Schlegelberger B;
Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871
[TBL] [Abstract][Full Text] [Related]
16. Inadequate Rates of BRCA Testing with its Negative Consequences for Women with Epithelial Ovarian Cancer and their Families: an Overview of the Literature.
Hoskins PJ
Clin Oncol (R Coll Radiol); 2018 Aug; 30(8):472-483. PubMed ID: 29735311
[TBL] [Abstract][Full Text] [Related]
17. Breast and ovarian cancer referrals to the ACT Genetic Service: are we meeting guidelines?
Aitken L; Warwick L; Davis A
Intern Med J; 2017 Mar; 47(3):311-317. PubMed ID: 28019080
[TBL] [Abstract][Full Text] [Related]
18. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
19. Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
Rana HQ; Kipnis L; Hehir K; Cronin A; Jaung T; Stokes SM; Fekrmandi F; Vatnick D; Matulonis UA; Garber JE; Wright AA
Gynecol Oncol; 2021 Feb; 160(2):457-463. PubMed ID: 33229043
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
